Detanosal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y09NU9DS9B, chemically known as salicylic acid, 2-(diethylamino)ethyl ester but generally known as detanosal, which bears US NIH Compound Identifier 160413. European Medicines Agency schedules Detanosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07009MIG. The term DETANOSAL is an International Non-Proprietary Name. DETANOSAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule detanosal under HS 29221980 and SITC 51461. As of Q4 2014, DETANOSAL remains the US FDA Preferred Term for this commodity. Detanosal bears US NLM identifiers UMLS ID C2699602 and NCI Concept Code C77352. SMILES: O(CCN(CC)CC)C(=O)C1C(O)CCCC1.